The BA.5 subvariant has become the dominant COVID-19 strain in the U.S., characterized by high transmissibility and the ability to evade immunity from prior infections and vaccines. Dr. Eric Topol discusses the "immune escape" nature of the variant and the phenomenon of "Paxlovid rebound," where patients test positive again shortly after completing Pfizer's antiviral treatment.
